Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic (FACTA)

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mary Gamble, Columbia University Identifier:
First received: January 13, 2010
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):